BE871584A - Preparations pharmaceutiques - Google Patents

Preparations pharmaceutiques

Info

Publication number
BE871584A
BE871584A BE191383A BE191383A BE871584A BE 871584 A BE871584 A BE 871584A BE 191383 A BE191383 A BE 191383A BE 191383 A BE191383 A BE 191383A BE 871584 A BE871584 A BE 871584A
Authority
BE
Belgium
Prior art keywords
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
BE191383A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH546678A external-priority patent/CH639846A5/de
Priority claimed from CH546578A external-priority patent/CH642944A5/de
Priority claimed from CH940778A external-priority patent/CH644850A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BE871584A publication Critical patent/BE871584A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
BE191383A 1977-10-28 1978-10-27 Preparations pharmaceutiques BE871584A (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
LU78407 1977-10-28
LU78408 1977-10-28
CH546678A CH639846A5 (en) 1978-05-19 1978-05-19 Pharmaceutical preparations having antiandrogenic action, containing urea derivatives or hydantoin derivatives
CH546578A CH642944A5 (en) 1978-05-19 1978-05-19 Urea derivatives
CH940778A CH644850A5 (en) 1977-10-28 1978-09-07 Pharmaceutical preparations containing urea derivatives

Publications (1)

Publication Number Publication Date
BE871584A true BE871584A (fr) 1979-04-27

Family

ID=27509239

Family Applications (1)

Application Number Title Priority Date Filing Date
BE191383A BE871584A (fr) 1977-10-28 1978-10-27 Preparations pharmaceutiques

Country Status (15)

Country Link
US (1) US4234736A (fr)
JP (1) JPS5473754A (fr)
AU (2) AU522796B2 (fr)
BE (1) BE871584A (fr)
BR (1) BR7807115A (fr)
CA (2) CA1138334A (fr)
DE (1) DE2846945A1 (fr)
DK (1) DK481778A (fr)
FR (1) FR2407205A1 (fr)
GB (2) GB2008101B (fr)
IL (1) IL55774A (fr)
IT (1) IT1100904B (fr)
NL (1) NL7810562A (fr)
NZ (1) NZ188720A (fr)
SE (2) SE433304B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1220A1 (fr) * 1977-10-28 1979-07-20 Hoffmann La Roche Nouveaux derives d'imidazolidine
FI801184A7 (fi) * 1979-04-24 1981-01-01 F Hoffmann La Roche & Co Menetelmä imidatsolidiini-johdannaisten valmistamiseksi.
EP0091596B1 (fr) * 1982-04-08 1991-09-11 Shell Internationale Researchmaatschappij B.V. Hydantoins, préparation et application
JP2791156B2 (ja) * 1988-08-23 1998-08-27 ザ ヌトラスウィート カンパニー 強力甘味料としての置換アリール尿素
FR2656302B1 (fr) * 1989-12-22 1992-05-07 Roussel Uclaf Nouveau procede de preparation de l'anandron et derives de l'anandron.
FR2671348B1 (fr) * 1991-01-09 1993-03-26 Roussel Uclaf Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
USRE35956E (en) * 1991-01-09 1998-11-10 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
US5670641A (en) * 1995-06-02 1997-09-23 American Cyanamid Company 3-(3-aryloxyphenyl)-1-(substituted methyl)-S-triazine-2,4,6-oxo or thiotrione herbicidal agents
US7001911B2 (en) 2000-06-28 2006-02-21 Bristol-Myers Squibb Company Fused cyclic modulators of nuclear hormone receptor function
US20040077605A1 (en) 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
HUP0303172A3 (en) 2000-06-28 2006-05-29 Bristol Myers Squibb Co Selective androgen receptor modulators and methods for their identification, desing and use
US6953679B2 (en) 2000-09-19 2005-10-11 Bristol-Myers Squibb Company Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
EP1854798A3 (fr) 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Composés de succinimide hétérocyclique fondu et leurs analogies, modulateurs de la fonction de récepteur d'hormone nucléaire
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US7087636B2 (en) 2001-12-19 2006-08-08 Bristol-Myers Squibb Company Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
EP2299266A1 (fr) * 2003-12-19 2011-03-23 The Regents of the University of California Procédés et matériels pour évaluer les thérapies du cancer de la prostate
NZ550102A (en) * 2004-02-24 2010-10-29 Univ California Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
US7709517B2 (en) * 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
BRPI0709771B1 (pt) 2006-03-27 2022-01-25 The Regents Of The University Of California Composto e composição farmacêutica
NZ596260A (en) * 2006-03-29 2013-05-31 Univ California Diarylthiohydantoin compounds
TWI469971B (zh) 2007-10-26 2015-01-21 Univ California 二芳基乙內醯脲類化合物
EP3124481B1 (fr) 2010-02-16 2018-03-28 Aragon Pharmaceuticals, Inc. Modulateurs de récepteur d'androgène et utilisations associées
WO2014052237A1 (fr) 2012-09-26 2014-04-03 Aragon Pharmaceuticals, Inc. Anti-androgènes pour le traitement du cancer de la prostate non métastatique, résistant à la castration
EP2945628B1 (fr) 2013-01-15 2020-04-15 Aragon Pharmaceuticals, Inc. Modulateur du récepteur des androgènes en combinaison d'acetate d'abiraterone et de prednisone pour le traitement du cancer de la prostate
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
KR20240096623A (ko) 2017-10-16 2024-06-26 아라곤 파마슈티컬스, 인코포레이티드 비-전이성 거세-저항성 전립선암의 치료를 위한 항-안드로겐

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629779A (fr) *
US3134663A (en) * 1957-07-23 1964-05-26 Geigy Chem Corp Herbicidal composition and method employing hydantoins
GB997037A (en) 1962-03-19 1965-06-30 Ici Ltd New hydrantoin derivatives
IL31416A0 (en) 1968-02-19 1969-03-27 Bayer Ag 5-imino-2-oxo-imidazolidines,their preparation and use as herbicides
NL6904420A (fr) * 1968-03-28 1969-09-30
DK123717B (da) * 1968-11-25 1972-07-24 Sumitomo Chemical Co 3-(3',5'-Dihalogenphenyl)-imidazolidin-2,4-dionderivater med mirobicid virkning.
US3676456A (en) * 1970-02-27 1972-07-11 Ciba Geigy Corp Derivatives of 3-aryl-5-alkylhydantoins
JPS5136332B1 (fr) * 1970-12-09 1976-10-07
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
IL45459A (en) 1973-09-03 1978-01-31 Ciba Geigy Ag 1-(dichlorofluoromethylthio)-3-phenyl-imidazolidine-2,4-dione derivatives their preparation and their use as bactericides and fungicides
FR2329276A1 (fr) 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant

Also Published As

Publication number Publication date
IT7829207A0 (it) 1978-10-27
IT1100904B (it) 1985-09-28
SE433304B (sv) 1984-05-21
JPS5473754A (en) 1979-06-13
NL7810562A (nl) 1979-05-02
AU551161B2 (en) 1986-04-17
FR2407205B1 (fr) 1982-12-31
SE8202106L (sv) 1982-04-01
US4234736A (en) 1980-11-18
BR7807115A (pt) 1979-05-15
GB2087870A (en) 1982-06-03
GB2087870B (en) 1982-11-10
IL55774A0 (en) 1978-12-17
CA1138334A (fr) 1982-12-28
IL55774A (en) 1982-04-30
DE2846945A1 (de) 1979-05-03
FR2407205A1 (fr) 1979-05-25
SE7811193L (sv) 1979-04-29
AU4096278A (en) 1980-05-01
AU522796B2 (en) 1982-06-24
GB2008101B (en) 1982-09-08
CA1137091A (fr) 1982-12-07
DK481778A (da) 1979-04-29
NZ188720A (en) 1984-12-14
GB2008101A (en) 1979-05-31
AU8105182A (en) 1982-07-08

Similar Documents

Publication Publication Date Title
NO801863L (no) Farmasoeytiske preparater.
SE7803527L (sv) Lekemedelsdosenhet
IT1100904B (it) Preparati farmaceutici
FI803767L (fi) Cortikosteroid innehaollande farmaceutiska blandningar
BE864359A (fr) Compositions pharmaceutiques antioestrogenes
SE7809373L (sv) Farmaceutiskt anvendbara 5-hydroxi-1h-imidazol-4-karboxamidderivat
IT1095377B (it) Composizione farmaceutica
NL188645C (nl) 1-azaxanthon-3-carbonzuurverbindingen en farmaceutische preparaten die deze verbindingen bevatten.
NL7806573A (nl) Preparaten met geneeskundige werkzaamheid.
NL7903769A (nl) Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan.
NL7801921A (nl) Farmaceutische preparaten.
BE863710A (nl) Pesticide-preparaten
NL7809626A (nl) Therapeutische preparaat.
FI802690A7 (fi) Dermatologiskt laekemedel
AT353973B (de) Kosmetischer wirkstoff
BE853569A (nl) Medicinale preparaten
FI783049A7 (fi) Farmaceutiskt aktiva(omega-aminoalkoxi)dibenzyler
DD128671A5 (de) Pharmazeutische mittel
NL184896C (nl) Pyranochinolinonderivaten en gevormde farmaceutische preparaten die deze bevatten.
NL7805158A (nl) Farmaceutisch preparaat.
SE7600480L (sv) Farmaceutiskt anvendbara 2-aminoacetamido-alfa-fenylbensylidenaminoalk
NL7812344A (nl) Farmaceutisch preparaat.
BE848975A (fr) Preparations pharmaceutiques contraceptive
NL7803601A (nl) Farmaceutische preparaten.
SE8000268L (sv) Farmaceutiska beredningar

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: F. HOFFMANN-LA ROCHE & CIE S.A.

Effective date: 19871031